PUBLISHER: The Business Research Company | PRODUCT CODE: 1942480
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942480
Brain and neuroimaging devices are medical tools designed to capture the structure, function, or pharmacology of the brain and identify areas impacted by neurological disorders. These devices are utilized to examine cognitive functions and diagnose neurological conditions.
The primary types of brain and neuroimaging devices include functional magnetic resonance imaging (fMRI), computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), magnetoencephalography (MEG), and others. Positron emission tomography (PET) is an imaging technique that gauges cellular metabolic activity in body tissues using radioactive elements. These devices have varied applications in conditions such as Parkinson's disease, traumatic brain injury, epilepsy, dementia, sleep disorders, and are extensively utilized in hospitals, diagnostic centers, and ambulatory surgical centers.
Tariffs are impacting the brain and neuroimaging devices market by increasing costs of imported magnets, detectors, imaging sensors, advanced electronics, and system components used in MRI, CT, PET, and MEG devices. Hospitals and diagnostic centers in North America and Europe are most affected due to heavy reliance on imported high-value imaging systems, while Asia-Pacific faces increased production costs for global exports. These tariffs are raising capital equipment costs and delaying upgrades. However, they are also encouraging localized assembly, regional manufacturing partnerships, and domestic development of advanced neuroimaging technologies.
The brain and neuroimaging devices market research report is one of a series of new reports from The Business Research Company that provides brain and neuroimaging devices market statistics, including brain and neuroimaging devices industry global market size, regional shares, competitors with a brain and neuroimaging devices market share, detailed brain and neuroimaging devices market segments, market trends and opportunities, and any further data you may need to thrive in the brain and neuroimaging devices industry. This brain and neuroimaging devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The brain and neuroimaging devices market size has grown strongly in recent years. It will grow from $44.1 billion in 2025 to $46.7 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increasing incidence of neurological disorders, expansion of diagnostic imaging centers, adoption of advanced MRI and CT technologies, growth of neurological research programs, rising use of EEG-based diagnostics.
The brain and neuroimaging devices market size is expected to see strong growth in the next few years. It will grow to $59.26 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing demand for early detection of brain disorders, expansion of precision neurology applications, growing investments in neuroimaging research, rising adoption of hybrid imaging systems, increasing integration of imaging with digital health platforms. Major trends in the forecast period include increasing adoption of ai-assisted neuroimaging analysis, rising use of high-resolution brain imaging modalities, growing integration of multimodal imaging techniques, expansion of functional brain mapping applications, enhanced focus on early neurological diagnosis.
The increasing prevalence of traumatic brain injuries (TBI) is expected to drive growth in the brain and neuroimaging devices market in the coming years. TBI refers to damage to the brain caused by a sudden external force or trauma, which can affect an individual's physical, cognitive, emotional, and behavioral functions. Brain and neuroimaging devices are used to diagnose, assess, and manage TBI, helping physicians detect bleeding, fractures, or structural abnormalities. For example, in October 2023, according to Neural Regeneration Research, a China-based peer-reviewed journal focused on neuroscience, approximately 69 million people worldwide suffer from TBI each year. Consequently, the rising prevalence of traumatic brain injuries is fueling growth in the brain and neuroimaging devices market.
Rising healthcare expenditure is also expected to support the growth of the brain and neuroimaging devices market. Healthcare expenditure includes financial resources allocated to medical treatments, hospital care, medications, and public health initiatives by governments, businesses, and individuals. Increasing healthcare spending is driven by the growing prevalence of chronic diseases, which require long-term and costly care. Greater investment in healthcare enables the adoption of advanced diagnostic technologies, expands access to specialized imaging services, improves infrastructure, facilitates early disease detection, and supports better patient outcomes. For instance, in May 2024, the UK Office for National Statistics reported that total healthcare expenditure rose by 5.6% in nominal terms in 2023, representing a 0.9% increase compared to 2022. Therefore, rising healthcare expenditure is contributing to the growth of the brain and neuroimaging devices market.
Major companies operating in the brain and neuroimaging devices market are focusing on artificial intelligence (AI)-enabled technologies to enhance diagnostic capabilities and maintain a competitive edge. AI-integrated solutions, such as Neuro Suite, provide comprehensive support for neurological disorders. For example, in April 2023, TeraRecon, Inc., a US-based medical imaging equipment developer, launched the Neuro Suite. This AI-assisted clinical solution supports the diagnosis and monitoring of neurological diseases, including neuro-oncology, multiple sclerosis, and dementia, by offering radiologists access to a range of AI-powered neuroimaging modalities.
Major companies operating in the brain and neuroimaging devices market are GE HealthCare, Siemens AG, Koninklijke Philips, Canon Medical Systems Corporation, Hitachi Medical Systems, EB Neuro S.p.A., Neurosoft, MinFound Medical Systems Co. Ltd., Elekta, Toshiba Corporation, Shimadzu Corporation, Bruker Corporation, PerkinElmer Inc., Carl Zeiss Meditec AG, Fujifilm Holdings Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, RIMED Ltd., Advanced Brain Monitoring Inc., Compumedics Limited
Western Europe was the largest region in the brain and neuroimaging devices market in 2025. North America was the second-largest region in the global brain and neuroimaging devices market report. Africa. was the smallest region in the brain and neuroimaging devices market. The regions covered in the brain and neuroimaging devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the brain and neuroimaging devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The brain and neuroimaging devices market consists of sales of imaging equipment for brain and nerves such as functional magnetic resonance imaging, computed tomography, positron emission tomography (pet), electroencephalography, magnetoencephalography, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Brain And Neuroimaging Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses brain and neuroimaging devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for brain and neuroimaging devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The brain and neuroimaging devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.